Cordlife Group (SGX:P8A) ROE % Adjusted to Book Value : -68.39% (As of Jun. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Cordlife Group ROE % Adjusted to Book Value?

Cordlife Group's ROE % for the quarter that ended in Jun. 2024 was -19.15%. Cordlife Group's PB Ratio for the quarter that ended in Jun. 2024 was 0.28. Cordlife Group's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was -68.39%.

Cordlife Group ROE % Adjusted to Book Value Historical Data

The historical data trend for Cordlife Group's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cordlife Group ROE % Adjusted to Book Value Chart

Cordlife Group Annual Data

Trend

Jun13

Jun14

Jun15

Jun16

Jun17

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

5.38

6.57

6.07

5.92

4.37

Cordlife Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															4.24	7.31	3.14	3.20	-68.39

Competitive Comparison of Cordlife Group's ROE % Adjusted to Book Value

For the Diagnostics & Research subindustry, Cordlife Group's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cordlife Group's ROE % Adjusted to Book Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Cordlife Group's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Cordlife Group's ROE % Adjusted to Book Value falls into.

Cordlife Group ROE % Adjusted to Book Value Calculation

Cordlife Group's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	2.62%	/	0.60
	=	4.37%

Cordlife Group's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-19.15%	/	0.28
	=	-68.39%

Cordlife Group ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Cordlife Group's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Cordlife Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cordlife Group Ltd (SGX:P8A) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Yishun Industrial Street 1, Number 06-01/09, A\'Posh Bizhub, Singapore, SGP, 768160

Website

https://www.cordlife.com

Cordlife Group Ltd is a consumer healthcare company dedicated to safeguarding the well-being of mother and child. Cordlife has processing and storage facilities in six key markets across Asia, namely Singapore, Hong Kong, Malaysia, India, Indonesia, and the Philippines. The company has two segments - The Banking segment, which comprises cord blood, cord lining, and cord tissue services. The Diagnostics segment comprises Metascreen, which is a non-invasive metabolic screening test specially designed for newborn babies, a non-invasive prenatal testing service and Eyescreen, a paediatric eye-screening service.

Cordlife Group Headlines

No Headlines